Literature DB >> 3773980

Susceptibility of clinical isolates of yeasts to anti-fungal agents.

S M Hussain Qadri, D J Flournoy, S G Qadri, E G Ramirez.   

Abstract

The antimicrobial activity of amphotericin B, 5-fluorocytosine, nystatin, clotrimazole and miconazole were compared in vitro against 244 strains of yeasts that had been isolated from clinical specimens. The yeasts used in this study included 20 species of Candida, Cryptococcus, Saccharomyces Geotrichum, Rhodotorula, Torulopsis and Trichosporon. The majority of the strains (78%) had an MIC of less than or equal to 0.5 microgram/ml for amphotericin B, 81% an MIC of less than or equal to 1 microgram/ml for 5-fluorocytosine, 99% less than or equal to 8 micrograms/ml for nystatin, 91%, less than or equal to 8.0 micrograms/ml for clotrimazole and 98% had an MIC of less than or equal to 4.0 for miconazole. Of the anti-fungal agents tested, 5-fluorocytosine and nystatin were found to have the greatest antifungal activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3773980     DOI: 10.1007/bf00437125

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  20 in total

Review 1.  Fungal sterols and the mode of action of the polyene antibiotics.

Authors:  J M Hamilton-Miller
Journal:  Adv Appl Microbiol       Date:  1974       Impact factor: 5.086

2.  Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria.

Authors:  R A Woods; M Bard; I E Jackson; D J Drutz
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

3.  Evaluation of a modified Wickerham medium for identifying medically important yeasts.

Authors:  E D Adams; B H Cooper
Journal:  Am J Med Technol       Date:  1974-09

4.  Fatal disseminated candidiasis due to amphotericin-B-resistant Candida guilliermondii.

Authors:  J D Dick; B R Rosengard; W G Merz; R K Stuart; G M Hutchins; R Saral
Journal:  Ann Intern Med       Date:  1985-01       Impact factor: 25.391

5.  Infections in cancer patients on a protected environment-prophylactic antibiotic program.

Authors:  G P Bodey; V Rodriguez
Journal:  Am J Med       Date:  1975-10       Impact factor: 4.965

6.  Sensitivity of clinical yeast isolates in Kuwait against a number of antifungal agents.

Authors:  M A Ghannoum; H F Sharif; H Al-Gharreer
Journal:  Mykosen       Date:  1984-08

Review 7.  Opportunistic infection: a review.

Authors:  A S Klainer; W R Beisel
Journal:  Am J Med Sci       Date:  1969-12       Impact factor: 2.378

8.  Development of resistance to amphotericin B in Candida lusitaniae infecting a human.

Authors:  D Pappagianis; M S Collins; R Hector; J Remington
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

9.  Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality.

Authors:  F Meunier-Carpentier; T E Kiehn; D Armstrong
Journal:  Am J Med       Date:  1981-09       Impact factor: 4.965

View more
  6 in total

1.  Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.

Authors:  F Galán-Sánchez; P García-Martos; C Rodríguez-Ramos; P Marín-Casanova; J Mira-Gutiérrez
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

2.  Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations.

Authors:  R Pelletier; J Peter; C Antin; C Gonzalez; L Wood; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 3.  Overview of medically important antifungal azole derivatives.

Authors:  R A Fromtling
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

4.  Candida norvegensis peritonitis and invasive disease in a patient on continuous ambulatory peritoneal dialysis.

Authors:  H Nielsen; J Stenderup; B Bruun; J Ladefoged
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

5.  In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.

Authors:  J M Hernández Molina; J Llosá; A Martinez Brocal; A Ventosa
Journal:  Mycopathologia       Date:  1992-04       Impact factor: 2.574

Review 6.  Two cases of vaginitis caused by itraconazole-resistant Saccharomyces cerevisiae and a review of recently published studies.

Authors:  Vincenzo Savini; Chiara Catavitello; Assunta Manna; Marzia Talia; Fabio Febbo; Andrea Balbinot; Francesco D'Antonio; Giovanni Di Bonaventura; Claudio Celentano; Marco Liberati; Raffaele Piccolomini; Domenico D'Antonio
Journal:  Mycopathologia       Date:  2008-04-29       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.